Clinical Trial Update: A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating linifanib (ABT-869) in combination with carboplatin and paclitaxel in Japanese patients with non-small cell lung cancer has completed. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Linifanib (ABT-869) (linifanib)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: AbbVie | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED